R21CA283588 (CHIU, BRIAN C-H)Apr 2, 2024 - Mar 31, 2026 NIH RNA m6A modifications and treatment response in multiple myeloma Role: Principal Investigator |
|
R56CA282891 (CHIU, BRIAN C-H)Sep 22, 2023 - Aug 31, 2024 NIH Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities Role: Principal Investigator |
|
R01CA280637 (CHIU, BRIAN C-H)Aug 1, 2023 - Jul 31, 2028 NIH Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma Role: Principal Investigator |
|
R33CA269100 (CHIU, BRIAN C-H)Jun 8, 2022 - May 31, 2025 NIH A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research Role: Principal Investigator |
|
U01CA271014 (VACHON, CELINE M)May 1, 2022 - Apr 30, 2027 NIH Impact of Genetic susceptibility along the continuum from MGUS to MM Role: Co-Investigator |
|
(XIE, TAO)Jan 1, 2022 - Dec 31, 2024 The Michael J. Fox Foundation Clinical disease course and healthcare access in black PD patients Role: Co-Investigator |
|
75N91019P00819 (CHIU, BRIAN C-H)Sep 18, 2019 - Aug 31, 2020 NIH Collection of study document and pathology slides for AsiaLymph study in Taiwan Role: Principal Investigator |
|
R01CA223662 (CHIU, BRIAN C-H)Jul 6, 2018 - Jun 30, 2025 NIH Epigenomic markers of circulating cell-free DNA and treatment response in multiple myeloma Role: Principal Investigator |
|
OT2OD026557 (GREENLAND, PHILIP)Jun 1, 2018 - Aug 31, 2023 NIH Illinois Precision Medicine Consortium Role: Co-Investigator |
|
R21HL140531 (CALIP, GREGORY SAMPANG)Jan 1, 2018 - Dec 31, 2020 NIH Risk of venous thromboembolism following diagnosis and treatment of multiple myeloma: differences by race Role: Co-Investigator |
|
P30ES027792 (AHSAN, HABIBUL)Sep 30, 2017 - Mar 31, 2027 NIH ChicAgo Center for Health and EnvironmenT (CACHET) Role: Co-Investigator |
|
R21MD011439 (CHIU, BRIAN C-H)Sep 25, 2017 - May 22, 2021 NIH Using epigenomic subtyping to understand the racial differences in lymphoma Role: Principal Investigator |
|
UG3OD023189 (GREENLAND, PHILIP)Jul 6, 2016 - May 31, 2018 NIH Illinois Precision Medicine Consortium (IPMC) Role: Co-Investigator |
|
R01CA186646 (BROWN, ELIZABETH E)Jul 1, 2014 - May 31, 2021 NIH Molecular characterization of myeloma and related asymptomatic precursor states Role: Co-Investigator |
|
HSN261201000690P (CHIU, BRIAN C-H)Sep 27, 2010 - May 1, 2015 NIH Taiwan study center of the AsiaLymph Study Role: Principal Investigator |
|
R01CA134786 (COZEN, WENDY)Aug 1, 2010 - May 31, 2017 NIH Genome Wide Admixture Scan for Multiple Myeloma in African Americans Role: Co-Investigator |
|
R03CA139576 (EVENS, ANDREW M)Jul 17, 2009 - Dec 30, 2011 NIH Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival Role: Co-Investigator |
|
R03CA132153 (CHIU, BRIAN C-H)Sep 27, 2007 - Aug 31, 2010 NIH Risk Factors for Molecularly Defined Subgroups of Lymphoma: A Pooled Analysis Role: Principal Investigator |
|
R01CA100555 (CHIU, BRIAN C-H)Apr 1, 2005 - Feb 29, 2012 NIH Lymphoma Defined Cytogenetically for Epidemiologic Study Role: Principal Investigator |
|
R25CA100600 (VAN HORN, LINDA VERNER)May 1, 2004 - Apr 30, 2010 NIH Postdoctoral Training Program in Cancer Epidemiology Role: Co-Investigator |